Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with williams or cornelia de lange syndrome

Human Vaccines

Volumn 7, Issue 6, 2011, Pages 613-617

  Esposito, Susanna ^a   Selicorni, Angelo ^a   Daleno, Cristina ^a   Valzano, Antonia ^a   Cerutti, Marta ^a   Galeone, Carlotta ^a,b   Consolo, Silvia ^a   Menni, Francesca ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

A H1N1 influenza vaccine; Cornelia de lange syndrome; Pandemic influenza; Pediatrics; Williams syndrome

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DE LANGE SYNDROME; DIARRHEA; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EATING HABIT; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RESISTANCE; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALAISE; MALE; PANDEMIC INFLUENZA; RHINITIS; SCHOOL CHILD; SEROCONVERSION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; VOMITING; WILLIAMS BEUREN SYNDROME;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; CHILD; DE LANGE SYNDROME; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; PANDEMICS; POLYSORBATES; SQUALENE; WILLIAMS SYNDROME;

EID: 79959347402     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.6.15133     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb. Mortal. Wkly 2010; 59:1-68.
2. ECDC. On the use of specific pandemic influenza vaccines. Accessed 19 August 2009; Available at: http://www.ecdc.europa.eu/en/healthtopics/ Documents/0908-Influenza-AH1N1-Onthe-use-of-specific-pandemic-influenza- vaccines.pdf.
3. Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr Opin Infect Dis 2009; 22:244-9.
4. Castorina P, Selicorni A, Bedeschi R, Dalprà L, Larizza L. Genotype-phenotype correlation in two sets of monozygotic twins with Williams syndrome. Am J Med Genet 1997; 69:107-11. (Pubitemid 27111191)
5. Gagliardi C, Bonaglia MC, Selicorni A, Borgatti R, Giorda R. Unusual cognitive and behavioural profile in a Williams syndrome patient with atypical 7q11.23 deletion. J Med Genet 2003; 40:526-30. (Pubitemid 36843076)
6. Oliver C, Bedeschi MF, Blagowidow N, Carrico CS, Cereda A, Fitzpatrick DR, et al. Cornelia de Lange syndrome: extending the physical and psychological phenotype. Am J Med Genet A 2010; 152:1127-35.
7. Olioso G, Passarini A, Atzeri F, Milani D, Cereda A, Cerutti M, et al. Clinical problems and everyday abilities of a group of Italian adolescent and young adults with Cornelia de Lange syndrome. Am J Med Genet A 2009; 149:2532-7.
8. Liu J, Baynam G. Cornelia de Lange syndrome. Adv Exp Med Biol 2010; 685:111-23.
9. Martens MA, Wilson SJ, Reutens DC. Williams syndrome: a critical review of the cognitive, behavioral and neuroanatomical phenotype. J Child Psychol Psychiat 2008; 49:576-608. (Pubitemid 351713313)
10. Otsuka T, Fujinaka H, Kamimura T, Tanaka Y, Hayakawa H, Sato M, et al. Influenza vaccination in severely multiply handicapped persons/children. Vaccine 2006; 24:4096-101.
11. Otsuka T, Fujinaka H, Katsuyama, Iizawa M, Kinoshita S, Tanaka Y, et al. Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season. Vaccine 2007; 25:4521-4.
12. Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A(H1N1) virus infection: United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:941-7.
13. Halasa NB. Update on the 2009 pandemic influenza A H1N1 in children. Curr Opin Pediatr 2010; 22:83-7.
14. Rimmelzwaan G, McElhaney JE. Correlates of protections of influenza vaccines. Vaccine 2008; 26:41-4.
15. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424-35.
16. Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomized controlled trial. Lancet 2010; 375:49-55.
17. Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedule among older children, adolescents and adults: results from a vaccine safety datalink study. Am J Public Health 2009; 99:389-97.
18. Greenberg ME, Lai MH, Hartel GF, Wichems C, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-13.
19. Parkman PD, Hopps HE, Rastogi SC, Meyer HM Jr. Summary of clinical trials of influenza virus vaccine in adults. J Infect Dis 1977; 136:722-30.
20. Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J 2009; 28:563-71.
21. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52.
22. Menegon T, Baldo V, Bonello C, Dalla Costa D, Di Tommaso A, Trivello R. Influenza vaccines: antibody response to split virus and MF59-adjuvanted subunit virus in an adult population. Eur J Epidemiol 1999; 15:573-6. (Pubitemid 29400033)
23. Centers for Disease Control and Prevention (CDC). Accessed 18 January 2010. CDC protocol of real-time RT-PCR for swine influenza A (H1N1), 28 April 2009 revision 1 (30 April 2009). Available at: http://www.who.int/csr/resources/ publications/swineflu/realtimeptpcr/en/index.html.
24. Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, et al. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J Clin Virol 2010; 48:62-5.
25. Esposito S, Molteni CG, Daleno C, Valzano A, Fossali E, Da Dalt L, et al. Clinical importance and impact on the households of oseltamivir-resistant seasonal A/ H1N1 influenza virus in healthy children in Italy. Virol J 2010; 7:202.